Isoray - Treating Prostate Cancer with Brachytherapy
  • Patients
    • Patients
    • Why Brachytherapy?
    • Why Cesium-131?
    • Treatment Areas
      • Prostate
      • Brain
      • Gynecological
      • Head & Neck
      • Lung
    • Cesium Pioneers
    • Find a Doctor
    • Terms and Abbreviations
  • Clinicians
    • Clinicians
    • Cesium Pioneers
    • Why Brachytherapy?
    • Why Cesium-131?
    • Products
    • Conferences
  • About
    • About
      • Quality and Regulatory
    • Contact Isoray
    • News
    • Videos
    • Careers
    • Management Team
    • Events
    • Investors
      • Press Releases
      • ISR on NYSE
      • SEC Filings
      • Presentations
      • FAQ
      • Investor Contact
  • Find A Doctor
Select Page

Blu Build Featured on WTAT-TV in Charleston, SC

Jan 31, 2019

The world’s first use of the Blu Build Cesium-131 brachytherapy delivery system to treat prostate cancer at Hollings Cancer Center is an important development for prostate cancer patients and their doctors.  Here’s the WTAT-TV report.

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on Google+ (Opens in new window)

Related

Categories

  • Blog
  • Isoray News
  • Other
  • Physician Spotlight
  • Press Release
  • Prostate Cancer Awareness Month
  • Prostate News
  • Quarterly Results
  • Study
  • Surgeon Spotlight
  • Uncategorized
  • Patients
  • Clinicians
  • Cesium Pioneers
  • Why Brachytherapy?
  • Why Cesium-131?
  • About
  • Contact
  • News
  • Careers
  • Investors

About

Isoray passionately designs and develops innovative and personalized brachytherapy products that effectively treat many forms of cancer. We believe in pioneering solutions for life beyond your cancer.
  • Home
  • About
  • Contact
  • Terms of Use
  • Privacy Policy
  • Facebook
  • Twitter
  • RSS
Copyright 2019 Isoray Inc.
Disclosure: The physicians featured on this website may have prior or current relationships with IsoRay. These relationships may include, for example: membership on IsoRay’s Advisory Board; participation as a clinical investigator in research conducted on IsoRay products; provision of consultation or training services; or engagement as a prospective partner in the development of new products. Many of these physicians have received or continue to receive compensation from IsoRay in one form or another. The principal nature of a specific physician’s relationship is disclosed on this website adjacent to language featuring that physician.